267 related articles for article (PubMed ID: 29650563)
1. Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD.
Vedel-Krogh S; Nordestgaard BG; Lange P; Vestbo J; Nielsen SF
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29650563
[TBL] [Abstract][Full Text] [Related]
2. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
Pavord ID; Lettis S; Anzueto A; Barnes N
Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
4. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
[TBL] [Abstract][Full Text] [Related]
6. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
[TBL] [Abstract][Full Text] [Related]
7. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
[TBL] [Abstract][Full Text] [Related]
8. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.
Barnes NC; Sharma R; Lettis S; Calverley PM
Eur Respir J; 2016 May; 47(5):1374-82. PubMed ID: 26917606
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
[TBL] [Abstract][Full Text] [Related]
10. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
Cheng SL; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
[TBL] [Abstract][Full Text] [Related]
12. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
Couillard S; Larivée P; Courteau J; Vanasse A
Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.
Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A
Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252
[TBL] [Abstract][Full Text] [Related]
14. High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.
Greulich T; Tüffers J; Mager S; Eder A; Maxheim M; Alter P; Schmeck B; Vogelmeier CF
Respir Res; 2020 May; 21(1):106. PubMed ID: 32375777
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
[TBL] [Abstract][Full Text] [Related]
16. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis.
Cheng SL
Int J Chron Obstruct Pulmon Dis; 2018; 13():2775-2784. PubMed ID: 30233168
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
18. Association between COPD exacerbations and lung function decline during maintenance therapy.
Kerkhof M; Voorham J; Dorinsky P; Cabrera C; Darken P; Kocks JW; Sadatsafavi M; Sin DD; Carter V; Price DB
Thorax; 2020 Sep; 75(9):744-753. PubMed ID: 32532852
[TBL] [Abstract][Full Text] [Related]
19. Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research Datalink.
Landis SH; Suruki R; Hilton E; Compton C; Galwey NW
COPD; 2017 Aug; 14(4):382-388. PubMed ID: 28569614
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids, blood eosinophils, and FEV
Whittaker HR; Müllerova H; Jarvis D; Barnes NC; Jones PW; Compton CH; Kiddle SJ; Quint JK
Int J Chron Obstruct Pulmon Dis; 2019; 14():1063-1073. PubMed ID: 31213788
[No Abstract] [Full Text] [Related]
[Next] [New Search]
